Dexmedetomidine Hydrochloride Injection, Solution
Product Images NDC 65219-642

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine Hydrochloride (NDC 65219-642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dexme-img-01.jpg (Dexme Img 01)

FDA Label Image

Dexme-label-01.jpg (Dexme Label 01)

Dexme-label-01.jpg (Dexme Label 01)
This is a product label for Dexmedetomidine Injection, USP. It contains 200 mcg (base) per 2mL single-dose vial for intravenous infusion. The medication must be diluted before use and any unused portion should be discarded. The label includes the lot number 404191 and a lot/expiry number for tracking purposes.*
FDA Label Image

Dexme-label-02.jpg (Dexme Label 02)

Dexme-label-02.jpg (Dexme Label 02)
This text appears to be a description of a pharmaceutical product. It includes details such as the drug name (Dexmedetomidine), dosage information, administration instructions, recommended storage conditions, manufacturer information (Fresenius Kabi), and cautionary advice for use. It is recommended to refer to the original documentation for accurate and complete information about the product.*
FDA Label Image

Dexme-struc-01.jpg (Dexme Struc 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.